A new drug combinatory effect prediction algorithm on the cancer cell based on gene expression and dose-response curve

C. Pankaj Goswami, L. Cheng, P. S. Alexander, A. Singal, L. Li

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Gene expression data before and after treatment with an individual drug and the IC20 of dose-response data were utilized to predict two drugs' interaction effects on a diffuse large B-cell lymphoma (DLBCL) cancer cell. A novel drug interaction scoring algorithm was developed to account for either synergistic or antagonistic effects between drug combinations. Different core gene selection schemes were investigated, which included the whole gene set, the drug-sensitive gene set, the drug-sensitive minus drug-resistant gene set, and the known drug target gene set. The prediction scores were compared with the observed drug interaction data at 6, 12, and 24 hours with a probability concordance (PC) index. The test result shows the concordance between observed and predicted drug interaction ranking reaches a PC index of 0.605. The scoring reliability and efficiency was further confirmed in five drug interaction studies published in the GEO database.

Original languageEnglish (US)
Pages (from-to)80-90
Number of pages11
JournalCPT: Pharmacometrics and Systems Pharmacology
Volume4
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Drug interactions
Dose-response Curve
Drug Interactions
Gene expression
Gene Expression
Cancer
Drugs
Genes
Cells
Prediction
Cell
Pharmaceutical Preparations
Neoplasms
Concordance
Gene
Lymphoma, Large B-Cell, Diffuse
Drug Combinations
Scoring
Interaction
Databases

ASJC Scopus subject areas

  • Modeling and Simulation
  • Pharmacology (medical)

Cite this

A new drug combinatory effect prediction algorithm on the cancer cell based on gene expression and dose-response curve. / Goswami, C. Pankaj; Cheng, L.; Alexander, P. S.; Singal, A.; Li, L.

In: CPT: Pharmacometrics and Systems Pharmacology, Vol. 4, No. 2, 01.02.2015, p. 80-90.

Research output: Contribution to journalArticle

@article{c823d6536b814e9b933e50b922d4014b,
title = "A new drug combinatory effect prediction algorithm on the cancer cell based on gene expression and dose-response curve",
abstract = "Gene expression data before and after treatment with an individual drug and the IC20 of dose-response data were utilized to predict two drugs' interaction effects on a diffuse large B-cell lymphoma (DLBCL) cancer cell. A novel drug interaction scoring algorithm was developed to account for either synergistic or antagonistic effects between drug combinations. Different core gene selection schemes were investigated, which included the whole gene set, the drug-sensitive gene set, the drug-sensitive minus drug-resistant gene set, and the known drug target gene set. The prediction scores were compared with the observed drug interaction data at 6, 12, and 24 hours with a probability concordance (PC) index. The test result shows the concordance between observed and predicted drug interaction ranking reaches a PC index of 0.605. The scoring reliability and efficiency was further confirmed in five drug interaction studies published in the GEO database.",
author = "Goswami, {C. Pankaj} and L. Cheng and Alexander, {P. S.} and A. Singal and L. Li",
year = "2015",
month = "2",
day = "1",
doi = "10.1002/psp4.9",
language = "English (US)",
volume = "4",
pages = "80--90",
journal = "CPT: Pharmacometrics and Systems Pharmacology",
issn = "2163-8306",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - A new drug combinatory effect prediction algorithm on the cancer cell based on gene expression and dose-response curve

AU - Goswami, C. Pankaj

AU - Cheng, L.

AU - Alexander, P. S.

AU - Singal, A.

AU - Li, L.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Gene expression data before and after treatment with an individual drug and the IC20 of dose-response data were utilized to predict two drugs' interaction effects on a diffuse large B-cell lymphoma (DLBCL) cancer cell. A novel drug interaction scoring algorithm was developed to account for either synergistic or antagonistic effects between drug combinations. Different core gene selection schemes were investigated, which included the whole gene set, the drug-sensitive gene set, the drug-sensitive minus drug-resistant gene set, and the known drug target gene set. The prediction scores were compared with the observed drug interaction data at 6, 12, and 24 hours with a probability concordance (PC) index. The test result shows the concordance between observed and predicted drug interaction ranking reaches a PC index of 0.605. The scoring reliability and efficiency was further confirmed in five drug interaction studies published in the GEO database.

AB - Gene expression data before and after treatment with an individual drug and the IC20 of dose-response data were utilized to predict two drugs' interaction effects on a diffuse large B-cell lymphoma (DLBCL) cancer cell. A novel drug interaction scoring algorithm was developed to account for either synergistic or antagonistic effects between drug combinations. Different core gene selection schemes were investigated, which included the whole gene set, the drug-sensitive gene set, the drug-sensitive minus drug-resistant gene set, and the known drug target gene set. The prediction scores were compared with the observed drug interaction data at 6, 12, and 24 hours with a probability concordance (PC) index. The test result shows the concordance between observed and predicted drug interaction ranking reaches a PC index of 0.605. The scoring reliability and efficiency was further confirmed in five drug interaction studies published in the GEO database.

UR - http://www.scopus.com/inward/record.url?scp=84936777089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936777089&partnerID=8YFLogxK

U2 - 10.1002/psp4.9

DO - 10.1002/psp4.9

M3 - Article

AN - SCOPUS:84936777089

VL - 4

SP - 80

EP - 90

JO - CPT: Pharmacometrics and Systems Pharmacology

JF - CPT: Pharmacometrics and Systems Pharmacology

SN - 2163-8306

IS - 2

ER -